FrontAce Scientific Co., Ltd
1 clinical trials · Sponsor
◉ Watch FrontAce Scientific Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries (NCT06539689) | FrontAce Scientific Co., Ltd | 2024-06-04 |
Track FrontAce Scientific Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.